Cariprazine for negative symptoms in early psychosis
A pilot study with a 6-month follow-up
Bibliographic Data
| ID | 15520971 |
|---|---|
| Authors | Sofia Pappa (0000-0002-6303-1547, West London Mental Health NHS Trust, corresponding author), Arturas Kalniunas (0000-0003-1002-6194, West London Mental Health NHS Trust), Jose Maret (West London Mental Health NHS Trust) |
| Year | 2023 |
| Volume | 14 |
| Pages | 1183912-1183912 |
| Publication date | 2023-06-22 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2023.1183912 |
| PMID | 37426095 |
| OpenAlex | W4381803826 |
| Language | EN |
| Citations received | 2 |
| References cited | 36 |
This pilot study suggests that cariprazine is a safe and effective treatment in early psychosis, particularly for the alleviation of negative symptoms which remains an area of unmet treatment need
Adverse effect · Agonist · Antipsychotic · Discontinuation · Partial agonist · Population · Positive and Negative Syndrome Scale · Psychiatry · Psychosis · Schizophrenia (object-oriented programming · Tolerability · Bipolar Disorder and Treatment · Medicine · Obsessive-Compulsive Spectrum Disorders · Psychology · Schizophrenia research and treatment · Internal Medicine
| Unique citing works | 2 |
|---|---|
| Citations per year | 1 |
| Citation span | 2024 - 2024 (1) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 2 |